Catalyst is a niche provider of clinical research
services through two established solutions.
Premier provider of multi-therapeutic
resourcing and CRO services helping to
drive healthcare innovations to patients in need.
A biotech-focused, niche oncology CRO
helping to bring next-generation therapies
to cancer patients in need.
Your success is based on finding real solutions and getting real results.
You deserve a partner who is fully invested in giving you their undivided attention.
Building a culture of customer through collaboration and doing what’s right.
Latest News
Highlights of ESMO 2023: The year of ADCs
By Andrew Zupnick, PhD, Vice President of Oncology Drug Development Cancer researchers from around the world converged on Madrid, Spain, in mid-October for the annual European Society of Medical Oncology (ESMO) conference. Excitement runs high for this event and the...
Catalyst Clinical Research Honored for Innovative Use of AI
Recognition from Medidata for our support of clients’ site selection New York - November 8, 2023 - Medidata recognized Catalyst Clinical Research at Medidata NEXT New York 2023 on Nov. 7 for its efforts with artificial intelligence (AI). Nick Dyer, Chief Executive...
Catalyst Clinical Research Named One of Fastest Growing Companies
For fourth consecutive year, CRO recognized for its growth and culture. RALEIGH, NC, 8 November 2023 – Catalyst Clinical Research ranked ninth in the Triangle Business Journal’s (TBJ) Fast 50, which was announced Nov. 8. This is the fourth consecutive year Catalyst...
“What makes a difference in this industry is how organizations stand behind their work. Catalyst has been hugely successful because of their integrity and commitment to their customers. No matter how big or small the project, they are your partner and that is why I continue to work with them.”
Mid-size Biopharma
